Skip to main content
. 2022 May 4;14(9):2290. doi: 10.3390/cancers14092290

Figure 5.

Figure 5

Figure 5

Response to denosumab therapy and radical resection of the GCTB of the second metacarpal followed by reconstruction with a 3D-printed patient-specific implant. (A) GCTB of the second metacarpal at the beginning of therapy; (B) X-ray taken after 13 doses of denosumab treatment; (C) Intraoperative image showing well-calcified tumor after dissection of surrounding soft tissue envelope; (D) 3D-printed patient-specific implant.